Avid Tradex Private Limited

Peptides are short chains of amino acids, the building blocks of proteins. They are typically shorter than proteins, with a range of 2 to 50 amino acids, while proteins are much longer, often consisting of hundreds or thousands of amino acids. Peptides play various roles in biological processes and can be found in many skincare products. 

Additional Information:

• Delivery Time: 3 WEEKS

Retatrutide is a weight-loss medication that's in development. It works by acting like three gut hormones that help balance appetite and metabolism. Phase 2 clinical trials found that people using retatrutide lost an average of 24% of their starting body weight.

Additional Information:

• Delivery Time: 3 WEEKS

Retatrutide (15 mg is a high potential dose, though the maximum tested in trials is 12 mg) is an investigational drug being developed by Eli Lilly primarily for the treatment of obesity and type 2 diabetes. It is not yet approved by the FDA or other regulatory bodies and is only available within clinical trial settings. 

Retatrutide is an experimental, once-weekly injection for significant weight loss in obesity, also being studied for Type 2 Diabetes and fatty liver disease, acting as a "triple G" (GLP-1, GIP, Glucagon) agonist for enhanced appetite control, fat burning, and metabolic improvement, showing over 24% weight loss in trials, though still in late-stage development with expected approval around 2026. 

Retatrutide is an investigational drug that is not yet approved for public use by regulatory bodies like the FDA or MHRA. The 60 mg dosage strength is a high dose used in ongoing Phase III clinical trials for conditions including obesity, type 2 diabetes, and related metabolic conditions. 

AOD9604 is an experimental research peptide investigated for potential uses in fat metabolism, weight management, and cartilage repair. It is not approved by the U.S. Food and Drug Administration (FDA) for human use and is often sold for research purposes only. 

Selank is a synthetic peptide developed in Russia and is primarily used for its anti-anxiety (anxiolytic) and cognitive-enhancing (nootropic) effects. It is available as a prescription medication in Russia for treating generalized anxiety disorder (GAD) but is not an FDA-approved drug in the United States and is generally classified as a research chemical in other countries. 

Semax is a nootropic and neuroprotective peptide medication approved and used in Russia and Eastern Europe for various medical conditions, as well as a cognitive enhancer. It has not been evaluated, approved, or marketed as a drug in the United States or most other countries, where it is generally considered a research chemical. 

Mazdutide (brand name Xinermei®) is approved in China for chronic weight management in adults with obesity or overweight, and for glycemic control in adults with type 2 diabetes. The 5mg dose is a common strength used as part of a once-weekly subcutaneous injection regimen. 

Survodutide (BI 456906) is an investigational dual agonist (GLP-1/glucagon) drug showing promise for treating obesity and metabolic dysfunction-associated steatohepatitis (MASH), leading to significant weight loss and liver improvement by targeting appetite, fat burning, and metabolic pathways. While specific 10mg dosing is part of ongoing Phase 3 trials (SYNCHRONIZE-1/2), it's currently used only in clinical studies, not for general prescription, aiming to manage metabolic health beyond just weight. 

The KLOW 80 blend, containing BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg), is a research peptide formulation primarily investigated for its potential synergistic effects in accelerated tissue healing, significant anti-inflammatory action, and overall cellular regeneration and skin rejuvenation. 

Tirzepatide is an FDA-approved injection used to treat type 2 diabetes mellitus, chronic weight management, and moderate to severe obstructive sleep apnea (OSA) in adults with obesity. It is marketed under the brand names Mounjaro and Zepbound. 

Digoxin tablets are used to treat heart conditions like atrial fibrillation (an irregular heartbeat) and congestive heart failure by making the heart beat more strongly and regularly, which improves blood circulation. It is also used to manage certain types of arrhythmias and atrial flutter in both adults and children. The medication helps the heart pump more efficiently, slows down the heart rate, and can reduce swelling in the hands and ankles. 

HGH (human growth hormone), specifically the synthetic form somatropin, is a prescription medication used to treat specific medical conditions in children and adults where the body does not produce enough natural growth hormone. The 24 IU designation refers to a common packaging or dosage size of the powder for reconstitution. 

Cagrilintide (10 mg) is a synthetic, long-acting amylin analogue primarily investigated in clinical trials for the treatment of obesity and type 2 diabetes. It is currently an investigational drug and is not yet approved by regulatory bodies like the FDA for medical use outside of clinical research settings. 

People most commonly use alpha-lipoic acid for obesity, nerve pain due to diabetes, and high levels of cholesterol or other fats in the blood. It is also used for altitude sickness, aging skin, and many other purposes, but there is no good scientific evidence to support many of these other uses.

GHRP-2 Acetate (Pralmorelin) is a growth hormone secretagogue used in research and sometimes for off-label purposes, primarily to stimulate the body's own growth hormone release, leading to potential benefits like muscle growth, fat loss, improved sleep, enhanced appetite, and accelerated tissue repair, though medical uses focus on growth hormone deficiency, requiring physician guidance for administration, usually via injection. 

GHRP-2 Acetate (Pralmorelin) is a synthetic peptide that acts as a growth hormone secretagogue, meaning it stimulates the body's natural production and release of growth hormone (GH) and IGF-1. It is primarily an investigational or research chemical and is not approved as a drug for general human use in most countries.